4 Largecap Five-Year and One-Year Winner Stocks to Watch for Future Multibagger Potential: Torrent Pharma, BSE, Union Bank and Laurus Labs
- October 30, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Torrent Pharma Rs 4,580. BSE Rs 3,502. Union Bank Rs 186.50. Laurus Labs Rs 2,244. Market caps from Rs 1.18 lakh crore to Rs 1.74 lakh crore. Data as of 29 Oct 2026.
Quick Answer
Torrent Pharma, BSE, Union Bank and Laurus Labs are the 4 picks in this five-year and one-year winner stocks watchlist, with market caps between Rs 1.18 lakh crore and Rs 1.74 lakh crore. Torrent Pharma stands out for the largest market cap at Rs 1,73,856 crore, while BSE offers the highest return on equity at 37.42%. PE ratios run from 6.52 to 108.57, so compare each one with its industry PE before investing. All figures are as of 29 October 2026.
Five-year and one-year winner stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Torrent Pharma, BSE, Union Bank and Laurus Labs meet that test, with market caps from Rs 1.18 lakh crore to Rs 1.74 lakh crore and Torrent Pharma offering the largest market cap at Rs 1,73,856 crore. Each of these companies has a five-year share price return of at least 100 per cent and a one-year share price return of at least 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a five-year share price return of at least 100 per cent and a one-year share price return of at least 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening five-year and one-year winner stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 29 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Five-Year and One-Year Winner Stocks and Why Do They Attract Multibagger Interest?
Five-year and one-year winner stocks are shares of large companies that have at least doubled investor money over five years and are still adding gains of twenty per cent or more over the last year, which shows both a long record and fresh strength. The four here cover pharmaceuticals, public sector banking, pharmaceutical ingredients and stock exchange services.
A long record of gains shows that the business has delivered over time, and a strong latest year shows that the market continues to reward it, so momentum is intact. For five-year and one-year winner stocks, both FY26 and the latest quarter showed growth. Whichever way you read five-year and one-year winner stocks, the common thread is rising profit backed by complete financial data. For five-year and one-year winner stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of five-year and one-year winner stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for five-year and one-year winner stocks before you decide.
Five-Year and One-Year Winner Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book
Prices are closing prices as of 29 October 2026. Union Bank has the lowest PE of the group at 6.52, while BSE posts the highest return on equity at 37.42%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Price to Book | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | 4,580 | 1,73,856 | 80.64 | 36.42 | 25.49% | 20.67 | 3,480.60 to 5,250.00 |
| BSE Ltd | 3,502 | 1,49,972 | 53.15 | 42.42 | 37.42% | 22.47 | 2,326.10 to 4,446.80 |
| Union Bank of India | 186.50 | 1,34,464 | 6.52 | 12.02 | 15.57% | 1.01 | 135.80 to 205.49 |
| Laurus Labs | 2,244 | 1,18,375 | 108.57 | 36.42 | 16.77% | 22.33 | 864.70 to 2,244.00 |
Torrent Pharma: 28.79% Profit CAGR Since FY22
Torrent Pharmaceuticals makes branded medicines for chronic therapies such as cardiac, gastro-intestinal and central nervous system care in India and overseas. It reported FY26 revenue of Rs 13,886.15 crore, up 20.34% year on year, and net profit of Rs 2,138.18 crore, up 11.87%. Net profit has compounded at 28.79% a year since FY22, while revenue has grown 12.38% a year. Operating margin was 22.70% in FY26.
In the June 2026 quarter, revenue rose 56.29% to Rs 4,909 crore and net profit grew 3.28% to Rs 566 crore. The share price has gained 194.63% over five years and 29.72% over the past year. Domestic institutions raised their holding from 9.28% in September 2025 to 12.87% in July 2026. The stock trades at a PE of 80.64 against an industry PE of 36.42, with a return on equity of 25.49%.
BSE: 78.30% Profit CAGR Since FY22
BSE Ltd operates one of India’s two major stock exchanges and earns from trading, listing, data and clearing services. It reported FY26 revenue of Rs 5,148.10 crore, up 59.07% year on year, and net profit of Rs 2,475.30 crore, up 87.94%. Net profit has compounded at 78.30% a year since FY22, while revenue has grown 56.26% a year. Operating margin was 68.39% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.
The stock trades at a PE of 53.15 against an industry PE of 42.42, with a return on equity of 37.42%. In the June 2026 quarter, revenue rose 63.41% to Rs 1,706.72 crore and net profit grew 62.15% to Rs 872.66 crore. The share price has gained 2101.66% over five years and 37.49% over the past year. Domestic institutions raised their holding from 13.51% in June 2025 to 24.15% in June 2026.
Union Bank: 37.80% Profit CAGR Since FY22
Union Bank of India is a large government-owned bank that serves retail, MSME and corporate customers across India. It reported FY26 total income of Rs 1,28,399.52 crore, up 0.19% year on year, and net profit of Rs 18,780.63 crore, up 4.80%. Net profit has compounded at 37.80% a year since FY22, while total income has grown 11.95% a year.
In the June 2026 quarter, total income rose 2.17% to Rs 32,660.24 crore and net profit grew 29.77% to Rs 5,368.17 crore. The share price has gained 249.43% over five years and 23.10% over the past year. Foreign investors raised their holding from 7.70% in June 2025 to 8.63% in June 2026. The stock trades at a PE of 6.52 against an industry PE of 12.02, below the sector average, with a return on equity of 15.57%. The dividend yield is 2.84%.
Laurus Labs: Revenue Up 22.01% in FY26
Laurus Labs makes active pharmaceutical ingredients and formulations and offers contract development and manufacturing services. It reported FY26 revenue of Rs 6,867.85 crore, up 22.01% year on year, and net profit of Rs 889.85 crore, up 151.08%. Revenue has compounded at 8.53% a year since FY22. Operating margin was 26.90% in FY26. The debt-to-equity ratio is 0.48.
The stock trades at a PE of 108.57 against an industry PE of 36.42, with a return on equity of 16.77%. In the June 2026 quarter, revenue rose 28.83% to Rs 2,035.49 crore and net profit grew 124.73% to Rs 361.99 crore. The share price has gained 221.40% over five years and 137.53% over the past year. Domestic institutions raised their holding from 11.94% in June 2025 to 13.74% in June 2026.
Five-Year and One-Year Winner Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these five-year and one-year winner stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR |
|---|---|---|---|---|---|
| Torrent Pharma | 13,886.15 | 2,138.18 | 20.34% | 12.38% | 28.79% |
| BSE | 5,148.10 | 2,475.30 | 59.07% | 56.26% | 78.30% |
| Union Bank | 1,28,399.52 | 18,780.63 | 0.19% | 11.95% | 37.80% |
| Laurus Labs | 6,867.85 | 889.85 | 22.01% | 8.53% | 1.68% |
Check the Univest Screener for live data on these five-year and one-year winner stocks
Institutional Holding in Torrent Pharma, BSE, Union Bank and Laurus Labs
Institutional holding shows who is backing these five-year and one-year winner stocks alongside the promoter. The table uses the latest reported quarter for each. BSE has the deepest institutional backing, with FII and DII together holding 45.47% as of June 2026. Domestic institutions increased their holding over the past year in Torrent Pharma (from 9.28% to 12.87%), BSE (from 13.51% to 24.15%) and Laurus Labs (from 11.94% to 13.74%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Torrent Pharma | 60.78% | 17.97% | 12.87% | 8.38% | July 2026 |
| BSE | Nil | 21.32% | 24.15% | 54.53% | June 2026 |
| Union Bank | 74.76% | 8.63% | 11.98% | 4.63% | June 2026 |
| Laurus Labs | 27.47% | 28.00% | 13.74% | 30.78% | June 2026 |
Risks to Weigh in Five-Year and One-Year Winner Stocks
Being careful with five-year and one-year winner stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Laurus Labs trades at a PE of 108.57 against an industry PE of 36.42, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Five-Year and One-Year Winner Stocks
Picking from five-year and one-year winner stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (12.02 to 42.42) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Torrent Pharma, BSE, Union Bank and Laurus Labs live prices.
Conclusion
Among five-year and one-year winner stocks, Torrent Pharma stands out for the largest market cap at Rs 1,73,856 crore, BSE for the highest return on equity at 37.42%, Union Bank for the lowest PE of the group at 6.52 and Laurus Labs for the strongest latest-quarter profit growth at 124.73%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing five-year and one-year winner stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Five-Year and One-Year Winner Stocks to Watch
Which are the best five-year and one-year winner stocks to watch for multibagger potential?
Ans. Torrent Pharma, BSE, Union Bank and Laurus Labs are the 4 names this list highlights, with market caps of Rs 1,73,856 crore, Rs 1,49,972 crore, Rs 1,34,464 crore and Rs 1,18,375 crore respectively. Torrent Pharma is notable for the largest market cap at Rs 1,73,856 crore. BSE stands out for the highest return on equity at 37.42%. Union Bank offers the lowest PE of the group at 6.52. Laurus Labs brings the strongest latest-quarter profit growth at 124.73%. These are watchlist names for five-year and one-year winner stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is BSE a good stock for long-term investors?
Ans. BSE has a return on equity of 37.42%, a PE of 53.15 against an industry PE of 42.42 and a market cap of Rs 1,49,972 crore. Net profit has compounded at 78.30% a year since FY22, and FY26 revenue rose 59.07% while June 2026 quarter net profit grew 62.15%. Long-term returns in five-year and one-year winner stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Union Bank become a multibagger from here?
Ans. Union Bank has already gained 249.43% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in five-year and one-year winner stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 37.80% a year since FY22, and FY26 revenue rose 0.19%. At a PE of 6.52 against an industry PE of 12.02, valuation should be checked against that growth before investing.
What is the market cap of Torrent Pharma, BSE, Union Bank and Laurus Labs?
Ans. As of 29 October 2026, Torrent Pharma has a market cap of Rs 1,73,856 crore, BSE has a market cap of Rs 1,49,972 crore, Union Bank has a market cap of Rs 1,34,464 crore and Laurus Labs has a market cap of Rs 1,18,375 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on five-year and one-year winner stocks.
What are the risks of investing in five-year and one-year winner stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Laurus Labs trades at a PE of 108.57 against an industry PE of 36.42, so earnings growth needs to hold up.
Why is Laurus Labs trading at a PE of 108.57?
Ans. Laurus Labs’ PE of 108.57 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 16.77%, latest-quarter profit growth of 124.73% and FY26 revenue growth of 22.01%, which also means the stock is more sensitive if growth slows. Investors in five-year and one-year winner stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Torrent Pharma, BSE, Union Bank and Laurus Labs?
Ans. As of the latest reported quarter, FII and DII together hold 30.84% of Torrent Pharma (17.97% and 12.87%), 45.47% of BSE (21.32% and 24.15%), 20.61% of Union Bank (8.63% and 11.98%) and 41.74% of Laurus Labs (28.00% and 13.74%). Rising institutional holding is a useful signal in five-year and one-year winner stocks, though it should be read with earnings trends rather than on its own.
